Listed

Assembly Biosciences, Inc.

ASMBNasdaqCIK 1426800HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$13.4m, Q2 FY2026
Operating income−$6.3m, Q2 FY2026
Net income−$3.9m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m0.0Revenue, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2024-11-07, accession 0000950170-24-123402.Report this figure7.2Revenue, Q4 FY2023, three months to 2023-12-31$7.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2025-03-20, accession 0000950170-25-042673. Derived: 12-month figure less the 9-month figure.Report this figure5.8Revenue, Q1 FY2024, three months to 2024-03-31$5.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-05-08, accession 0000950170-25-066991.Report this figure8.5Revenue, Q2 FY2024, three months to 2024-06-30$8.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-08-06, accession 0000950170-25-104060.Report this figure6.8Revenue, Q3 FY2024, three months to 2024-09-30$6.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-10, accession 0001193125-25-274277.Report this figure7.4Revenue, Q4 FY2024, three months to 2024-12-31$7.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-19, accession 0001193125-26-115992. Derived: 12-month figure less the 9-month figure.Report this figure9.4Revenue, Q1 FY2025, three months to 2025-03-31$9.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-07, accession 0001193125-26-211987.Report this figure9.6Revenue, Q2 FY2025, three months to 2025-06-30$9.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-349236.Report this figure10.8Revenue, Q3 FY2025, three months to 2025-09-30$10.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-10, accession 0001193125-25-274277.Report this figure42.5Revenue, Q4 FY2025, three months to 2025-12-31$42.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-19, accession 0001193125-26-115992. Derived: 12-month figure less the 9-month figure.Report this figure8.2Revenue, Q1 FY2026, three months to 2026-03-31$8.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-07, accession 0001193125-26-211987.Report this figure13.4Revenue, Q2 FY2026, three months to 2026-06-30$13.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-349236.Report this figure
Research and development$m10.8Research and development, Q3 FY2023, three months to 2023-09-30$10.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0000950170-24-123402.Report this figure11.0Research and development, Q4 FY2023, three months to 2023-12-31$11.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-20, accession 0000950170-25-042673. Derived: 12-month figure less the 9-month figure.Report this figure11.9Research and development, Q1 FY2024, three months to 2024-03-31$11.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0000950170-25-066991.Report this figure16.3Research and development, Q2 FY2024, three months to 2024-06-30$16.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-06, accession 0000950170-25-104060.Report this figure13.5Research and development, Q3 FY2024, three months to 2024-09-30$13.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001193125-25-274277.Report this figure14.3Research and development, Q4 FY2024, three months to 2024-12-31$14.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-19, accession 0001193125-26-115992. Derived: 12-month figure less the 9-month figure.Report this figure14.9Research and development, Q1 FY2025, three months to 2025-03-31$14.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-211987.Report this figure16.1Research and development, Q2 FY2025, three months to 2025-06-30$16.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349236.Report this figure16.6Research and development, Q3 FY2025, three months to 2025-09-30$16.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001193125-25-274277.Report this figure17.3Research and development, Q4 FY2025, three months to 2025-12-31$17.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-19, accession 0001193125-26-115992. Derived: 12-month figure less the 9-month figure.Report this figure14.9Research and development, Q1 FY2026, three months to 2026-03-31$14.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-211987.Report this figure14.9Research and development, Q2 FY2026, three months to 2026-06-30$14.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349236.Report this figure
Operating income$m(15.0)Operating income, Q3 FY2023, three months to 2023-09-30−$15.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-123402.Report this figure(12.6)Operating income, Q4 FY2023, three months to 2023-12-31−$12.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-20, accession 0000950170-25-042673. Derived: 12-month figure less the 9-month figure.Report this figure(10.7)Operating income, Q1 FY2024, three months to 2024-03-31−$10.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-066991.Report this figure(12.2)Operating income, Q2 FY2024, three months to 2024-06-30−$12.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-06, accession 0000950170-25-104060.Report this figure(11.0)Operating income, Q3 FY2024, three months to 2024-09-30−$11.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-274277.Report this figure(11.5)Operating income, Q4 FY2024, three months to 2024-12-31−$11.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0001193125-26-115992. Derived: 12-month figure less the 9-month figure.Report this figure(9.9)Operating income, Q1 FY2025, three months to 2025-03-31−$9.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211987.Report this figure(11.1)Operating income, Q2 FY2025, three months to 2025-06-30−$11.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349236.Report this figure(10.9)Operating income, Q3 FY2025, three months to 2025-09-30−$10.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-274277.Report this figure19.8Operating income, Q4 FY2025, three months to 2025-12-31$19.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0001193125-26-115992. Derived: 12-month figure less the 9-month figure.Report this figure(11.4)Operating income, Q1 FY2026, three months to 2026-03-31−$11.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211987.Report this figure(6.3)Operating income, Q2 FY2026, three months to 2026-06-30−$6.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349236.Report this figure
Interest expense$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-07, accession 0000950170-24-123402.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$33.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-20, accession 0000950170-25-042673. Derived: 12-month figure less the 9-month figure.Report this figurenot reported0.4Income tax, Q2 FY2024, three months to 2024-06-30$406.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-06, accession 0000950170-25-104060.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-10, accession 0001193125-25-274277.Report this figure(0.1)Income tax, Q4 FY2024, three months to 2024-12-31−$76.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-19, accession 0001193125-26-115992. Derived: 12-month figure less the 9-month figure.Report this figurenot reported0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-06, accession 0000950170-25-104060.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-10, accession 0001193125-25-274277.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-19, accession 0001193125-26-115992. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Net income$m(14.4)Net income, Q3 FY2023, three months to 2023-09-30−$14.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-123402.Report this figure(11.0)Net income, Q4 FY2023, three months to 2023-12-31−$11.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-20, accession 0000950170-25-042673. Derived: 12-month figure less the 9-month figure.Report this figure(9.1)Net income, Q1 FY2024, three months to 2024-03-31−$9.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-066991.Report this figure(11.2)Net income, Q2 FY2024, three months to 2024-06-30−$11.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-06, accession 0000950170-25-104060.Report this figure(9.6)Net income, Q3 FY2024, three months to 2024-09-30−$9.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-274277.Report this figure(10.3)Net income, Q4 FY2024, three months to 2024-12-31−$10.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0001193125-26-115992. Derived: 12-month figure less the 9-month figure.Report this figure(8.8)Net income, Q1 FY2025, three months to 2025-03-31−$8.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211987.Report this figure(10.2)Net income, Q2 FY2025, three months to 2025-06-30−$10.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349236.Report this figure(9.2)Net income, Q3 FY2025, three months to 2025-09-30−$9.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-274277.Report this figure22.1Net income, Q4 FY2025, three months to 2025-12-31$22.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0001193125-26-115992. Derived: 12-month figure less the 9-month figure.Report this figure(9.1)Net income, Q1 FY2026, three months to 2026-03-31−$9.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211987.Report this figure(3.9)Net income, Q2 FY2026, three months to 2026-06-30−$3.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349236.Report this figure
Diluted EPS$ per share(3.29)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$3.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0000950170-24-123402.Report this figurenot reported(1.66)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$1.66 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0000950170-25-066991.Report this figure(1.98)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$1.98 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-06, accession 0000950170-25-104060.Report this figure(1.51)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$1.51 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001193125-25-274277.Report this figurenot reported(1.17)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$1.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-211987.Report this figure(1.33)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$1.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-349236.Report this figure(0.72)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.72 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001193125-25-274277.Report this figurenot reported(0.54)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.54 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-211987.Report this figure(0.20)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-349236.Report this figure
Basic EPS$ per share(3.29)Basic EPS, Q3 FY2023, three months to 2023-09-30−$3.29 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0000950170-24-123402.Report this figurenot reported(1.66)Basic EPS, Q1 FY2024, three months to 2024-03-31−$1.66 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0000950170-25-066991.Report this figure(1.98)Basic EPS, Q2 FY2024, three months to 2024-06-30−$1.98 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-06, accession 0000950170-25-104060.Report this figure(1.51)Basic EPS, Q3 FY2024, three months to 2024-09-30−$1.51 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001193125-25-274277.Report this figurenot reported(1.17)Basic EPS, Q1 FY2025, three months to 2025-03-31−$1.17 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-211987.Report this figure(1.33)Basic EPS, Q2 FY2025, three months to 2025-06-30−$1.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-349236.Report this figure(0.72)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.72 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001193125-25-274277.Report this figurenot reported(0.54)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.54 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-211987.Report this figure(0.20)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-349236.Report this figure

Balance sheet

Cash and equivalents$32.3m, Q2 FY2026
Shareholders' equity$305.6m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m26.7Cash and equivalents, Q3 FY2023, at 2023-09-30$26.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-08, accession 0000950170-23-061134.Report this figure19.8Cash and equivalents, FY2023, at 2023-12-31$19.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-20, accession 0000950170-25-042673.Report this figure18.7Cash and equivalents, Q1 FY2024, at 2024-03-31$18.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-08, accession 0000950170-24-055680.Report this figure19.2Cash and equivalents, Q2 FY2024, at 2024-06-30$19.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0000950170-24-093998.Report this figure28.5Cash and equivalents, Q3 FY2024, at 2024-09-30$28.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0000950170-24-123402.Report this figure38.3Cash and equivalents, FY2024, at 2024-12-31$38.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-19, accession 0001193125-26-115992.Report this figure23.4Cash and equivalents, Q1 FY2025, at 2025-03-31$23.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0000950170-25-066991.Report this figure24.0Cash and equivalents, Q2 FY2025, at 2025-06-30$24.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-06, accession 0000950170-25-104060.Report this figure22.5Cash and equivalents, Q3 FY2025, at 2025-09-30$22.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-10, accession 0001193125-25-274277.Report this figure58.5Cash and equivalents, FY2025, at 2025-12-31$58.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-349236.Report this figure31.1Cash and equivalents, Q1 FY2026, at 2026-03-31$31.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-211987.Report this figure32.3Cash and equivalents, Q2 FY2026, at 2026-06-30$32.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-349236.Report this figure
Current assets$m49.7Current assets, Q3 FY2023, at 2023-09-30$49.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-061134.Report this figure134Current assets, FY2023, at 2023-12-31$133.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-20, accession 0000950170-25-042673.Report this figure117Current assets, Q1 FY2024, at 2024-03-31$117.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-08, accession 0000950170-24-055680.Report this figure113Current assets, Q2 FY2024, at 2024-06-30$112.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093998.Report this figure98.2Current assets, Q3 FY2024, at 2024-09-30$98.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123402.Report this figure116Current assets, FY2024, at 2024-12-31$115.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-19, accession 0001193125-26-115992.Report this figure95.5Current assets, Q1 FY2025, at 2025-03-31$95.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066991.Report this figure77.5Current assets, Q2 FY2025, at 2025-06-30$77.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-06, accession 0000950170-25-104060.Report this figure237Current assets, Q3 FY2025, at 2025-09-30$236.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-10, accession 0001193125-25-274277.Report this figure255Current assets, FY2025, at 2025-12-31$254.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349236.Report this figure233Current assets, Q1 FY2026, at 2026-03-31$232.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-211987.Report this figure328Current assets, Q2 FY2026, at 2026-06-30$328.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349236.Report this figure
Total assets$m51.6Total assets, Q3 FY2023, at 2023-09-30$51.6m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-08, accession 0000950170-23-061134.Report this figure137Total assets, FY2023, at 2023-12-31$136.8m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-20, accession 0000950170-25-042673.Report this figure120Total assets, Q1 FY2024, at 2024-03-31$119.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-08, accession 0000950170-24-055680.Report this figure115Total assets, Q2 FY2024, at 2024-06-30$115.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0000950170-24-093998.Report this figure100Total assets, Q3 FY2024, at 2024-09-30$100.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0000950170-24-123402.Report this figure119Total assets, FY2024, at 2024-12-31$119.2m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-19, accession 0001193125-26-115992.Report this figure99.0Total assets, Q1 FY2025, at 2025-03-31$99.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0000950170-25-066991.Report this figure80.8Total assets, Q2 FY2025, at 2025-06-30$80.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-06, accession 0000950170-25-104060.Report this figure240Total assets, Q3 FY2025, at 2025-09-30$240.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-10, accession 0001193125-25-274277.Report this figure258Total assets, FY2025, at 2025-12-31$257.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-349236.Report this figure236Total assets, Q1 FY2026, at 2026-03-31$235.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001193125-26-211987.Report this figure331Total assets, Q2 FY2026, at 2026-06-30$330.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-349236.Report this figure
Current liabilities$m7.1Current liabilities, Q3 FY2023, at 2023-09-30$7.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-061134.Report this figure39.2Current liabilities, FY2023, at 2023-12-31$39.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-20, accession 0000950170-25-042673.Report this figure38.8Current liabilities, Q1 FY2024, at 2024-03-31$38.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-08, accession 0000950170-24-055680.Report this figure41.3Current liabilities, Q2 FY2024, at 2024-06-30$41.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093998.Report this figure41.6Current liabilities, Q3 FY2024, at 2024-09-30$41.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123402.Report this figure47.8Current liabilities, FY2024, at 2024-12-31$47.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-19, accession 0001193125-26-115992.Report this figure46.6Current liabilities, Q1 FY2025, at 2025-03-31$46.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066991.Report this figure47.3Current liabilities, Q2 FY2025, at 2025-06-30$47.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-06, accession 0000950170-25-104060.Report this figure53.4Current liabilities, Q3 FY2025, at 2025-09-30$53.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-10, accession 0001193125-25-274277.Report this figure48.8Current liabilities, FY2025, at 2025-12-31$48.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349236.Report this figure35.0Current liabilities, Q1 FY2026, at 2026-03-31$35.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-211987.Report this figure23.4Current liabilities, Q2 FY2026, at 2026-06-30$23.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349236.Report this figure
Total liabilities$m9.9Total liabilities, Q3 FY2023, at 2023-09-30$9.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-08, accession 0000950170-23-061134.Report this figure95.7Total liabilities, FY2023, at 2023-12-31$95.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-20, accession 0000950170-25-042673.Report this figure87.3Total liabilities, Q1 FY2024, at 2024-03-31$87.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-08, accession 0000950170-24-055680.Report this figure80.6Total liabilities, Q2 FY2024, at 2024-06-30$80.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0000950170-24-093998.Report this figure74.3Total liabilities, Q3 FY2024, at 2024-09-30$74.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0000950170-24-123402.Report this figure85.8Total liabilities, FY2024, at 2024-12-31$85.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-19, accession 0001193125-26-115992.Report this figure71.9Total liabilities, Q1 FY2025, at 2025-03-31$71.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0000950170-25-066991.Report this figure62.7Total liabilities, Q2 FY2025, at 2025-06-30$62.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-06, accession 0000950170-25-104060.Report this figure57.3Total liabilities, Q3 FY2025, at 2025-09-30$57.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-10, accession 0001193125-25-274277.Report this figure50.8Total liabilities, FY2025, at 2025-12-31$50.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001193125-26-349236.Report this figure36.9Total liabilities, Q1 FY2026, at 2026-03-31$36.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001193125-26-211987.Report this figure25.2Total liabilities, Q2 FY2026, at 2026-06-30$25.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001193125-26-349236.Report this figure
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m41.7Shareholders' equity, Q3 FY2023, at 2023-09-30$41.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0000950170-24-123402.Report this figure41.1Shareholders' equity, FY2023, at 2023-12-31$41.1m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-19, accession 0001193125-26-115992.Report this figure32.6Shareholders' equity, Q1 FY2024, at 2024-03-31$32.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-06, accession 0000950170-25-104060.Report this figure34.7Shareholders' equity, Q2 FY2024, at 2024-06-30$34.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-274277.Report this figure26.0Shareholders' equity, Q3 FY2024, at 2024-09-30$26.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-274277.Report this figure33.4Shareholders' equity, FY2024, at 2024-12-31$33.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349236.Report this figure27.1Shareholders' equity, Q1 FY2025, at 2025-03-31$27.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349236.Report this figure18.1Shareholders' equity, Q2 FY2025, at 2025-06-30$18.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349236.Report this figure183Shareholders' equity, Q3 FY2025, at 2025-09-30$182.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-274277.Report this figure207Shareholders' equity, FY2025, at 2025-12-31$206.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349236.Report this figure199Shareholders' equity, Q1 FY2026, at 2026-03-31$198.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349236.Report this figure306Shareholders' equity, Q2 FY2026, at 2026-06-30$305.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349236.Report this figure

Cash flow

Operating cash flow−$15.5m, Q2 FY2026
Capital expenditure$0, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(13.8)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$13.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0000950170-24-123402. Derived: 9-month figure less the 6-month figure.Report this figure73.6Operating cash flow, Q4 FY2023, three months to 2023-12-31$73.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-20, accession 0000950170-25-042673. Derived: 12-month figure less the 9-month figure.Report this figure(18.4)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$18.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0000950170-25-066991.Report this figure(17.1)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$17.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-06, accession 0000950170-25-104060. Derived: 6-month figure less the 3-month figure.Report this figure(15.2)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$15.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001193125-25-274277. Derived: 9-month figure less the 6-month figure.Report this figure(0.4)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$407.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-19, accession 0001193125-26-115992. Derived: 12-month figure less the 9-month figure.Report this figure(23.4)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$23.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-211987.Report this figure(16.8)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$16.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-349236. Derived: 6-month figure less the 3-month figure.Report this figure(15.1)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$15.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001193125-25-274277. Derived: 9-month figure less the 6-month figure.Report this figure14.2Operating cash flow, Q4 FY2025, three months to 2025-12-31$14.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-19, accession 0001193125-26-115992. Derived: 12-month figure less the 9-month figure.Report this figure(22.1)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$22.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-211987.Report this figure(15.5)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$15.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-349236. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.1Capital expenditure, Q3 FY2023, three months to 2023-09-30$136.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0000950170-24-123402. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2023, three months to 2023-12-31$71.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-20, accession 0000950170-25-042673. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$14.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0000950170-25-066991.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$14.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-06, accession 0000950170-25-104060. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001193125-25-274277. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-19, accession 0001193125-26-115992. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-211987.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001193125-26-349236. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$42.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001193125-25-274277. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$24.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-19, accession 0001193125-26-115992. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$19.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-211987.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001193125-26-349236. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)18.85m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares48.4Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3048,448,399 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-08, accession 0000950170-23-061134.Report this figure4.3Diluted shares (weighted), Q1 FY2023, three months to 2023-03-314,251,037 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-08, accession 0000950170-24-055680.Report this figure4.4Diluted shares (weighted), Q2 FY2023, three months to 2023-06-304,355,007 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0000950170-24-093998.Report this figure4.4Diluted shares (weighted), Q3 FY2023, three months to 2023-09-304,380,444 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0000950170-24-123402.Report this figure5.5Diluted shares (weighted), Q1 FY2024, three months to 2024-03-315,483,313 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0000950170-25-066991.Report this figure5.6Diluted shares (weighted), Q2 FY2024, three months to 2024-06-305,642,752 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-06, accession 0000950170-25-104060.Report this figure6.4Diluted shares (weighted), Q3 FY2024, three months to 2024-09-306,351,431 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001193125-25-274277.Report this figure7.5Diluted shares (weighted), Q1 FY2025, three months to 2025-03-317,506,321 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-211987.Report this figure7.7Diluted shares (weighted), Q2 FY2025, three months to 2025-06-307,655,854 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349236.Report this figure12.7Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3012,686,122 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001193125-25-274277.Report this figure16.9Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3116,900,232 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-211987.Report this figure18.9Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3018,853,646 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349236.Report this figure

Shares outstanding: 20.36mShares outstanding, period not labelled, at 2026-08-0720,360,596 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349236.Report this figure at Aug 7, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. Listed shows no prices and gives no investment advice.